Articles and Editorials|

A data-driven approach to the development of medical devices

News Content 1920x630@2x

In the May edition of the ONdrugDelivery magazine, SHL’s Manager of Data and Process Innovation Frederick Gertz, Ph.D, provides an in-depth analysis on the advantages and challenges of becoming a data-driven organization in the medical technology sector.

In a digitalized era, where various tech giants are driving the newest data science trends and reaping results from data-driven decisions, the pharma and medical device industry seems to be moving at a relatively moderate pace. Although it is quite understandable, with life science companies having extraordinary requirements in terms of quality and regulatory standards, this article offers further insights into how digital transformation could benefit these organizations in terms of producing quality results from multiple aspects of development and production.

“Data-driven organizations can better plan logistics, adaptably shift workloads and quickly solve problems,” Gertz said. He also breaks down how transparent data could well streamline communication between designers and manufacturers, thus, giving support in developing products that warrant manufacturability and usability. “By creating a single source of truth, stakeholders across the organization can more easily interact and ultimately collaborate to make products with the highest level of value to everyone,” he explained.

As a leading solutions provider in the drug delivery industry, SHL continues to evolve and adapt to industry changes, implementing data-driven methodologies that ensure better development processes for autoinjector devices.

Download the full article here, or read it online at ONdrugDelivery (log in required).

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

In the Pre-filled Syringes and Injection Devices Issue of ONdrug Delivery Magazine, published ahead of the 2023 PDA Universe of Pre-filled Syringes and Injection Devices Conference, SHL Medical’s Edwin Hendrawan, Yi-Chi Lu, and Christian Walter detail how simulation technologies have been crucial in continuously strengthening the company’s global manufacturing operations and expansion plans.